Lee Sang Jin, Wu Zhenzhen, Huang Mengyu, Liang Chao, Huang Ziqi, Chen Siyuan, Rajasekar Vidhyashree, Abdalla Mohamed Mahmoud, Nah Haram, Heo Dong Nyoung, Kwon Il Keun, Cho Min-Jai, Kim Seong Jun, Sohn Seil, Kim Su-Hwan, Sugimura Ryohichi, Yiu Cynthia Kar Yung
Biofunctional Materials, Division of Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR, PR China.
Paediatric Dentistry, Faculty of Dentistry, Prince Philip Dental Hospital, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR, PR China.
Mater Today Bio. 2025 Jan 4;31:101451. doi: 10.1016/j.mtbio.2025.101451. eCollection 2025 Apr.
Recently, injectable hydrogels have garnered significant attention in tissue engineering due to their controlled flowability, strong plasticity, adaptability, and good biocompatibility. However, research on readily injectable -forming hydrogels capable of forming functional three-dimensional (3D) tissue condensations remains limited. This study explores the development and evaluation of a carboxymethyl chitosan (CMCTS)/oxidized hyaluronic acid (oHA) hydrogel incorporated with silver sulfadiazine (AgSD) for tissue engineering applications with inherent antibacterial activity. Through physicochemical analysis, the optimal formulation of CMCTS/oHA hydrogels was established. The hydrogel demonstrated excellent injectability, enabling minimally invasive delivery. cytotoxicity assays identified 0.1 % AgSD as the optimal concentration, supporting cell proliferation while exhibiting antimicrobial efficacy against and . studies revealed complete hydrogel degradation and good biocompatibility, with no adverse tissue reactions. The hydrogel's ability to form 3D cell aggregates and support tissue regeneration underscores its potential for future 3D tissue engineering applications. Consequently, the injectable CMCTS/oHA/AgSD hydrogel developed in this study holds significant potential for application in a wide range of bioengineering fields, including antibacterial substance delivery systems and 3D tissue engineering, indicating potential for future clinical application.
近年来,可注射水凝胶因其可控的流动性、强大的可塑性、适应性和良好的生物相容性而在组织工程领域备受关注。然而,对于能够形成功能性三维(3D)组织凝聚物的易注射成型水凝胶的研究仍然有限。本研究探索了一种含有磺胺嘧啶银(AgSD)的羧甲基壳聚糖(CMCTS)/氧化透明质酸(oHA)水凝胶用于具有固有抗菌活性的组织工程应用的开发与评估。通过物理化学分析,确定了CMCTS/oHA水凝胶的最佳配方。该水凝胶表现出优异的可注射性,能够实现微创给药。细胞毒性试验确定0.1%的AgSD为最佳浓度,在支持细胞增殖的同时对……和……表现出抗菌效果。研究表明水凝胶完全降解且具有良好的生物相容性,无不良组织反应。水凝胶形成3D细胞聚集体并支持组织再生的能力突出了其在未来3D组织工程应用中的潜力。因此,本研究开发的可注射CMCTS/oHA/AgSD水凝胶在包括抗菌物质递送系统和3D组织工程在内的广泛生物工程领域具有巨大的应用潜力,显示出未来临床应用的可能性。